Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
U. Farkhutdinov, A. Mirchaidarov, S. Farkhutdinov (Ufa, Russian Federation). Intravenous immunoglobulin in community acquired pneumonia. Eur Respir J 2011; 38: Suppl. 55, 818

Member's Comments

No comment yet.

Related content which might interest you: The effect of intravenous immunoglobulin on active oxygen forms production in patients with community acquired pneumonia Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 The effect of intravenous immunoglobulin on oxygen-dependent metabolism of blood cells in patients with community acquired pneumonia Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012 Effectiveness of the empirical administration of antibiotics in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Initial intravenous antibiotic regimen in patients hospitalized for community acquired pneumonia (CAP) in France Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003 Efficacy of intravenous immunoglobulin therapy on the incidence of pneumonia in Iranian patients with common variable immunodeficiency Source: Eur Respir J 2004; 24: Suppl. 48, 357s Year: 2004 Usefulness of urinary pneumococcal antigen testing in patients with community acquired pneumonia Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009 Severe mixed community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Management of community acquired pneumonia Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Management of community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Intravenous steroids in the treatment of community-acquired pneumonia (CAP) Source: Eur Respir J 2004; 24: Suppl. 48, 50s Year: 2004 Corticosteroids and community-acquired pneumonia Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Switch from intravenous to oral antibiotic therapy in hospitalized patients with non-severe community acquired pneumonia Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections Year: 2010 Treatment with intravenous immunoglobulin (IVG) in children with humoral immune deficiencies and recurrent respiratory tract infections Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001 Impact of determination of urine pneumococcal antigen in the diagnosis of community acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Hyponatraemia in community acquired pneumonia (CAP) in childhood Source: Eur Respir J 2003; 22: Suppl. 45, 318s Year: 2003 Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Community acquired pneumonia Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia? Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Management of severe community acquired pneumonia Source: Virtual Congress 2020 – German programme 2020 Year: 2020